Eledon Pharmaceuticals (ELDN)
NASDAQ:ELDN
US Market

Eledon Pharmaceuticals (ELDN) Income Statement

Compare
820 Followers

Eledon Pharmaceuticals Income Statement

Last quarter (Q4 2024), Eledon Pharmaceuticals's total revenue was $192.00K, a decrease of -65.71% from the same quarter last year. In Q4, Eledon Pharmaceuticals's net income was $-57.09M. See Eledon Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 120.00K
Gross Profit
$ 0.00$ -374.00K$ -373.00K$ -195.00K$ -63.00K
Operating Expenses
$ 70.58M$ 43.00M$ 39.78M$ 36.87M$ 16.18M
Depreciation and Amortization
$ 0.00$ 43.00M$ 373.00K$ 195.00K$ 183.00K
EBITDA
$ 0.00$ 0.00$ -87.59M$ -36.66M$ -23.03M
Operating Income
$ 0.00$ -43.00M$ 8.49M$ -36.87M$ -18.46M
Other Income/Expenses
$ 0.00$ 2.67M$ 462.00K$ 7.00K$ -4.75M
Pretax Income
$ -35.75M$ -40.33M$ -87.97M$ -36.86M$ -23.21M
Net Income
$ -35.32M$ -40.33M$ -87.50M$ -34.51M$ -22.81M
Per Share Metrics
Basic EPS
$ -0.73$ 0.00$ -6.13$ -2.33$ -15.72
Diluted EPS
$ -0.07$ -1.64$ -6.13$ -2.33$ -15.72
Weighted Average Shares Outstanding
48.54M 24.62B 14.29M 14.82M 1.45M
Weighted Average Shares Outstanding (Diluted)
485.44M 24.62M 14.29M 14.82M 1.45M
Currency in USD

Eledon Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis